Evaluating the patients' experience after switching from natalizumab intravenous to subcutaneous administration. Analysis of a case series
MULTIPLE SCLEROSIS JOURNAL(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined